Ipamorelin vs Hexarelin: GHRP Selectivity Research

Ipamorelin and hexarelin sit at opposite ends of the GHRP selectivity spectrum. Hexarelin is the most potent GH secretagogue in the class but with the largest off-target hormone release; ipamorelin is the cleanest GHRP but with a more modest pulse. This comparison summarises the published literature relevant to laboratory research.

At-a-glance comparison

| Attribute | Ipamorelin | Hexarelin | |---|---|---| | Class | Pentapeptide GHRP (GHS-R agonist) | Hexapeptide GHRP (GHS-R agonist) | | GH pulse potency (published) | Moderate | High — among the most potent GHRPs | | Prolactin release | Minimal (cleanest GHRP) | Notable elevation reported | | Cortisol / ACTH release | Minimal | Notable elevation reported | | Tachyphylaxis (receptor desensitisation) | Low at typical research doses | Reported with chronic dosing | | Cardiac CD36 binding (published) | Not characterised as primary | Characterised — cardioprotection research | | Typical research dosing | 100-300 mcg per administration | 100-200 mcg per administration |

Mechanism

Both bind GHS-R 1a on pituitary somatotrophs. Hexarelin has additional reported binding at cardiac CD36 — the basis for a small but distinct cardioprotection research literature that ipamorelin does not share.

Published research highlights

• Ipamorelin (Novo Nordisk, 1998) was specifically developed to retain GHRP potency while eliminating prolactin and cortisol release.
• Hexarelin is most-cited for cardioprotective endpoints in ischemia-reperfusion models via CD36 binding — a unique feature in the GHRP class.
• Tachyphylaxis with chronic hexarelin dosing is well-documented in published research; ipamorelin shows minimal tachyphylaxis at typical research doses.

Selecting between them in research

• For clean GH-axis research without confounding hormone elevations: ipamorelin.
• For cardiac CD36 / cardioprotection research: hexarelin (no other GHRP substitutes).
• For maximum GH pulse amplitude with off-target tolerance: hexarelin.

Combination research

Both are routinely combined with GHRH analogs (CJC-1295, sermorelin, tesamorelin) for additive pulse amplitude. Ipamorelin is the preferred GHRP for long-running combination protocols because of its low tachyphylaxis and clean hormone profile.

Frequently asked research questions

Why is ipamorelin called the "cleanest" GHRP? Published receptor-binding and hormone-release data show minimal prolactin and cortisol elevation compared with GHRP-2, GHRP-6, and hexarelin.

Is hexarelin still relevant if ipamorelin is cleaner? Yes — hexarelin's cardiac CD36 binding gives it a research niche (cardioprotection) that ipamorelin does not occupy.

How do they compare to GHRP-2 and GHRP-6? Ipamorelin is cleaner than both; hexarelin is more potent than both at GH release with more off-target activity.

Related research

• CJC-1295 vs Ipamorelin research comparison
• GHRP-2 vs GHRP-6 research comparison
• GHRP receptor pharmacology overview